Principal Financial Group Inc. Has $50.62 Million Stock Position in Axon Enterprise, Inc $AXON

Principal Financial Group Inc. increased its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 2.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 89,138 shares of the biotechnology company’s stock after buying an additional 2,207 shares during the period. Principal Financial Group Inc.’s holdings in Axon Enterprise were worth $50,624,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its position in Axon Enterprise by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 9,367,224 shares of the biotechnology company’s stock worth $5,319,928,000 after buying an additional 53,060 shares in the last quarter. Baillie Gifford & Co. lifted its position in Axon Enterprise by 1,198.7% during the 4th quarter. Baillie Gifford & Co. now owns 1,642,578 shares of the biotechnology company’s stock worth $932,869,000 after buying an additional 1,516,099 shares in the last quarter. Jennison Associates LLC lifted its position in Axon Enterprise by 53.8% during the 3rd quarter. Jennison Associates LLC now owns 943,944 shares of the biotechnology company’s stock worth $677,412,000 after buying an additional 330,213 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its position in Axon Enterprise by 23.0% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 838,289 shares of the biotechnology company’s stock worth $476,089,000 after buying an additional 156,647 shares in the last quarter. Finally, Northern Trust Corp lifted its position in Axon Enterprise by 1.6% during the 3rd quarter. Northern Trust Corp now owns 743,926 shares of the biotechnology company’s stock worth $533,871,000 after buying an additional 11,726 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $403.54 on Friday. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 2.29. The stock has a market cap of $32.51 billion, a PE ratio of 162.06, a price-to-earnings-growth ratio of 9.11 and a beta of 1.44. The stock has a 50-day moving average of $451.93 and a 200-day moving average of $527.52. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $885.91.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, beating analysts’ consensus estimates of $1.60 by $0.01. The company had revenue of $807.35 million during the quarter, compared to analysts’ expectations of $778.91 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.Axon Enterprise’s revenue was up 33.7% on a year-over-year basis. During the same period in the prior year, the business posted $1.47 EPS. As a group, sell-side analysts expect that Axon Enterprise, Inc will post 1.41 earnings per share for the current year.

Analyst Upgrades and Downgrades

AXON has been the topic of several research reports. Barclays reduced their price target on shares of Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating on the stock in a research report on Friday. The Goldman Sachs Group set a $535.00 price objective on Axon Enterprise in a report on Thursday. Piper Sandler dropped their price objective on Axon Enterprise from $690.00 to $674.00 and set an “overweight” rating for the company in a report on Thursday. Robert W. Baird set a $800.00 price objective on Axon Enterprise in a report on Wednesday, February 25th. Finally, Morgan Stanley set a $600.00 price objective on Axon Enterprise in a report on Thursday. Sixteen investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $712.75.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon reported Q1 revenue of about $807 million, up 33.7% year over year, with EPS of $1.61 topping consensus by a penny and management lifting its 2026 revenue growth outlook to 30%-32% while targeting roughly $450 million in free cash flow. Axon Raises Guidance With AI Revenue Up 700%
• Positive Sentiment: Analysts largely remained constructive, with multiple firms reiterating bullish ratings and new/raised price targets, citing strong ARR growth, AI-driven demand, and durable growth prospects. Axon Earns Buy Rating on Robust ARR Growth, AI-Driven Demand, and Underappreciated Profitability
• Positive Sentiment: Baltimore approved a $153 million police-equipment contract, highlighting continued public-safety spending that could benefit Axon’s body cameras, Tasers, and related software ecosystem. Baltimore police to get upgraded body-worn cameras, Tasers after city approves $153 million contract
• Neutral Sentiment: Some coverage noted that Q1 earnings slightly missed estimates and tariff-related margin pressure offset part of the strong revenue growth, creating a mixed read on near-term profitability. AXON Q1 Earnings Miss Estimates on Tariff-Driven Margins
• Negative Sentiment: The stock also faced some valuation pressure from mixed analyst target moves, including at least one notable cut even as ratings stayed positive. Axon Enterprise price target lowered by Citizens JMP

Insider Buying and Selling

In other news, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction dated Wednesday, February 25th. The stock was sold at an average price of $500.24, for a total value of $5,002,400.00. Following the completion of the sale, the chief executive officer directly owned 3,090,997 shares of the company’s stock, valued at $1,546,240,339.28. This represents a 0.32% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Erika Nardini sold 198 shares of the company’s stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $506.58, for a total value of $100,302.84. Following the completion of the sale, the director directly owned 1,946 shares of the company’s stock, valued at approximately $985,804.68. This trade represents a 9.24% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 13,855 shares of company stock worth $7,109,828 over the last quarter. Insiders own 4.40% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.